Login / Signup

A novel multiplex assay system based on 10 methylation markers for forensic identification of body fluids.

Hongzhi HuangXiaozhao LiuJuanbo ChengLinxia XuXimiao HeChao XiaoDaixin HuangShaohua Yi
Published in: Journal of forensic sciences (2021)
Identifying the source of body fluids found at a crime scene is an essential forensic step. Some methods based on DNA methylation played significant role in body fluids identification. Since DNA methylation is related to multiple factors, such as race, age, and diseases, it is necessary to know the methylation profile of a given population. In this study, we tested 19 body fluid-specific methylation markers in a Chinese Han population. A novel multiplex assay system based on the selected markers with smaller variation in methylation and stronger tissue-specific methylation were developed for the identification of body fluids. The multiplex assay were tested in 265 body fluid samples. A random forest model was established to predict the tissue source based on the methylation data of the 10 markers. The multiplex assay was evaluated by testing the sensitivity, the mixtures, and old samples. For the result, the novel multiplex assay based on 10 selected methylation markers presented good methylation profiles in all tested samples. The random forest model worked extremely well in predicting the source of body fluids, with an accuracy of 100% and 97.5% in training data and test data, respectively. The multiplex assay could accurately predict the tissue source from 0.5 ng genomic DNA, six-months-old samples and distinguish the minor component from a mixture of two components. Our results indicated that the methylation multiplex assay and the random forest model could provide a convenient tool for forensic practitioners in body fluid identification.
Keyphrases
  • high throughput
  • dna methylation
  • genome wide
  • real time pcr
  • gene expression
  • climate change
  • single cell
  • primary care
  • electronic health record
  • copy number
  • machine learning
  • general practice
  • circulating tumor